Trial result ·
Biomarker-dependent detection of contrast-associated acute kidney injury after intra-arterial contrast procedures: an exploratory randomized trial.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This trial looked at kidney harm after contrast dye was given into an artery. It included 76 people with peripheral artery disease. Most had a test scan of their blood vessels. People were first grouped by how well their kidneys worked at the start. By chance, one group got fluids alone. The other group got fluids plus atorvastatin and N-acetylcysteine. The team used creatinine and cystatin C blood tests to spot kidney harm.
What they found
The creatinine and cystatin C tests did not agree well. No person was flagged by both tests. Creatinine found 4 cases of kidney harm. Cystatin C found 7 more early cases. The gap between the tests changed with kidney function at the start. It stood out in people whose kidneys worked well at the start. Creatinine found few cases. This limited how firmly the team could judge the drugs. The choice of test seemed to change how well the drugs looked.
What it means for patients
How often kidney harm is found depends on which blood test is used. The authors say creatinine tests may miss early kidney changes. This may change how studies judge ways to prevent such harm. They say trials need to pick their main measures with care. They call for larger studies of more sensitive blood markers.
Why it is not certain yet
This was an exploratory trial with 76 people. Few cases were found with creatinine. So the drug effects could not be firmly judged. The drug results came from exploratory checks only. The trial was registered only after it began. The authors say larger studies are needed.
Source
Biomarker-dependent detection of contrast-associated acute kidney injury after intra-arterial contrast procedures: an exploratory randomized trial.
PubMed · PMID 42983348We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Peripheral artery disease publications